S H Kelkar and Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
November 03, 2023 at 08:15 am EDT
Share
S H Kelkar and Company Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 4,537.8 million compared to INR 4,124 million a year ago. Revenue was INR 4,572.4 million compared to INR 4,229 million a year ago. Net income was INR 293.2 million compared to INR 242.9 million a year ago. Basic earnings per share from continuing operations was INR 2.16 compared to INR 1.8 a year ago. Diluted earnings per share from continuing operations was INR 2.16 compared to INR 1.8 a year ago.
For the six months, sales was INR 8,971.2 million compared to INR 8,237.4 million a year ago. Revenue was INR 9,032.4 million compared to INR 8,381.5 million a year ago. Net income was INR 565.4 million compared to INR 458.9 million a year ago. Basic earnings per share from continuing operations was INR 4.16 compared to INR 3.4 a year ago. Diluted earnings per share from continuing operations was INR 4.16 compared to INR 3.4 a year ago.
S H Kelkar and Company Limited is an India-based fragrance and flavour company. The Company is engaged in the business of manufacturing, supplying and exporting of fragrances, flavours and aroma ingredients. The Company's segments include Fragrance and Flavours. Fragrance segment includes fragrance products that are used by various consumption categories, such as personal wash, soaps and detergents, sanitizers, home cleaners, fabric care and fine fragrances, among others. Flavours segment includes flavour products that are used as raw material by producers of baked goods, dairy products, beverages and pharmaceutical products. Its natural actives product portfolio includes Camisooth, AloeHeal, Glycibright, OleoKare and Puniblock. It offers products under SHK, Cobra, Auris, Wheel, Three Birds and Keva brands. It provides a range of research and testing services in the areas of biotechnology and microbiology research, cosmetic research, cosmetic biotechnology and custom synthesis.